Little Green Pharma company info

What does Little Green Pharma do?
Little Green Pharma (ASX:LGP) is a vertically integrated medicinal cannabis company that cultivates, manufactures, and distributes high-quality GMP-grade medicinal cannabis products to patients and partners around the world. With two global production sites, one in Denmark and one in Western Australia, LGP has the capacity to produce over 33 tonnes of medicinal cannabis biomass per annum. The company's products are sold under its own-branded and white-label ranges, and are exported to a number of countries including the UK, Germany, France, and New Zealand. Little Green Pharma is also actively engaged in research and development, with a focus on developing new and innovative cannabinoid-based medicines.
Little Green Pharma company media
Company Snapshot

Is Little Green Pharma a public or private company?

key
Ownership
Public

How many people does Little Green Pharma employ?

people
Employees
64

What sector is Little Green Pharma in?

pie chart
Sector
Health Care

Where is the head office for Little Green Pharma?

location pin
Head Office
Perth, Australia

What year was Little Green Pharma founded?

founded flag
Year Founded
2016
What does Little Green Pharma specialise in?
/Cannabis /Pharmaceutical /Health /Research and development /Medical cannabis

What are the products and/or services of Little Green Pharma?

Overview of Little Green Pharma offerings
Cultivation & Manufacturing: LGP cultivates high-quality medicinal cannabis in Australia, adhering to strict GMP standards for pharmaceutical production, ensuring a safe and reliable supply.
R&D Innovation Hub: LGP fuels the future of cannabis medicine with its research & development, exploring novel delivery methods and precise formulations for various conditions, like epilepsy and chronic pain.
Diverse Product Portfolio: LGP caters to varied patient needs with its expansive range of medicinal cannabis products, including oils, capsules, and sublingual tablets, offering flexibility and choice.
Clinical Trials: LGP actively participates in and drives clinical trials to gather robust evidence for the safety and efficacy of its cannabis medicines, solidifying their place in the medical landscape.
Global Expansion: LGP capitalises on Australia's cannabis cultivation expertise, reaching international markets with high demand, like Germany and the UK, expanding patient access beyond borders.
Collaboration Networks: LGP fosters open innovation through partnerships with universities, research institutions, and pharmaceutical companies, advancing cannabis-based medicine research and development collaboratively.

Who is in the executive team of Little Green Pharma?

Little Green Pharma leadership team
  • Mr. Angus McDougall Caithness
    Mr. Angus McDougall Caithness
    CFO & Executive Director
  • Ms. Fleta Jennifer Solomon
    Ms. Fleta Jennifer Solomon
    Executive Director
  • Mr. Paul  Long
    Mr. Paul Long
    Chief Executive Officer
  • Mr. Alistair  Warren B.A., L.L.B.
    Mr. Alistair Warren B.A., L.L.B.
    General Counsel & Company Secretary
  • Ms. Celia  Young
    Ms. Celia Young
    Head of Marketing
  • Dr. Leon  Warne
    Dr. Leon Warne
    Head of Research & Innovation
  • Ms. Gabriela  Franz
    Ms. Gabriela Franz
    Head of Commercial Operations Europe
  • Ms. Melanie  Pugliese
    Ms. Melanie Pugliese
    Head of Engagment